𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic predisposition to prostate cancer: Possible explanations for ethnic differences in risk

✍ Scribed by Shibata, Atsuko; Whittemore, Alice S.


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
276 KB
Volume
32
Category
Article
ISSN
0270-4137

No coin nor oath required. For personal study only.

✦ Synopsis


BACKGROUND.

It seems unlikely that the large ethnic differences in prostate cancer risk can be explained completely by ethnic differences in diet or other lifestyle characteristics. Instead, the differences may be due to ethnic variation in endogenous factors, such as androgen metabolism or inherited susceptibility. METHODS. We have reviewed the literature for evidence and support of ethnic variation in genetic susceptibility to prostate cancer as a reason for the ethnic differences in rates. RESULTS. We distinguish two types of ethnic variation: 1) variation in the prevalence of certain alleles of specific genes that confer modestly increased risk. Such variation might be reflected in ethnic differences in serum levels of androgens, their metabolites, or indicators of metabolism in the prostate; 2) variation in the prevalence of rare germline mutations conferring substantially increased risk. Such variation would be reflected in ethnic differences in familial aggregation of prostate cancer. We discuss the evidence in support of each of these two possibilities. CONCLUSIONS. Ethnic variation in polymorphic alleles of genes associated with modest fluctuations in risk could explain a large proportion of the ethnic difference in cancer risk. In contrast, rare mutations associated with substantially increased risk are likely to account for a smaller fraction of these differences.


📜 SIMILAR VOLUMES


Genetic variation of 3β-hydroxysteroid d
✍ Devgan, Sunita A.; Henderson, Brian E.; Yu, Mimi C.; Shi, Chen-Yang; Pike, Malco 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

## Background: Elevated prostatic dihydrotestosterone (dht) has been suggested to increase the risk of prostate cancer. the hsd3b2 gene encodes the type ii 3 beta-hydroxysteroid dehydrogenase: one of two enzymes that initiate the inactivation of dht. thus, the hsd3b2 gene is a candidate gene for pr